Liu L, Zhu L, Monteiro-Martins S, Griffin A, Vlahos L, Fujita M
medRxiv. 2024; .
PMID: 39417133
PMC: 11482997.
DOI: 10.1101/2024.10.10.24315041.
Fu C, Wang L, Cai W
Front Immunol. 2024; 15:1452849.
PMID: 39229261
PMC: 11368790.
DOI: 10.3389/fimmu.2024.1452849.
da Costa F, de Sarges K, da Silva R, Dos Santos E, Nascimento M, Rodrigues A
Int J Mol Sci. 2024; 25(16).
PMID: 39201427
PMC: 11354850.
DOI: 10.3390/ijms25168740.
Dmytrzak A, Lewandowska K, Boron A, Loniewska B, Grzesch N, Brodkiewicz A
Int J Mol Sci. 2024; 25(10).
PMID: 38791322
PMC: 11121548.
DOI: 10.3390/ijms25105284.
Rodrigues F, da Silva R, Dos Santos E, de Brito M, da Silva A, de Meira Leite M
Viruses. 2023; 15(5).
PMID: 37243282
PMC: 10220739.
DOI: 10.3390/v15051197.
Clonal hematopoiesis in cardiovascular disease and therapeutic implications.
Tall A, Fuster J
Nat Cardiovasc Res. 2022; 1(2):116-124.
PMID: 36337911
PMC: 9631799.
DOI: 10.1038/s44161-021-00015-3.
IL-6 signaling in acute exercise and chronic training: Potential consequences for health and athletic performance.
Nash D, Hughes M, Butcher L, Aicheler R, Smith P, Cullen T
Scand J Med Sci Sports. 2022; 33(1):4-19.
PMID: 36168944
PMC: 10092579.
DOI: 10.1111/sms.14241.
Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Janahiraman S, Too C, Lee K, Shahril N, Leong C
Genes (Basel). 2022; 13(7).
PMID: 35886067
PMC: 9323282.
DOI: 10.3390/genes13071284.
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients.
Salemi R, Gattuso G, Tomasello B, Lavoro A, Gaudio A, Libra M
Biomolecules. 2022; 12(5).
PMID: 35625609
PMC: 9138210.
DOI: 10.3390/biom12050681.
Characteristics of Interleukin-6 Signaling in Elective Cardiac Surgery-A Prospective Cohort Study.
Puchinger J, Ryz S, Nixdorf L, Edlinger-Stanger M, Lassnigg A, Wiedemann D
J Clin Med. 2022; 11(3).
PMID: 35160042
PMC: 8836792.
DOI: 10.3390/jcm11030590.
Associations of Immune Genetic Variability with Gulf War Illness in 1990-1991 Gulf War Veterans from the Gulf War Illness Consortium (GWIC) Multisite Case-Control Study.
Coller J, Tuke J, Wain T, Quinn E, Steele L, Abreu M
Brain Sci. 2021; 11(11).
PMID: 34827409
PMC: 8615505.
DOI: 10.3390/brainsci11111410.
Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis.
Xu H, Liu J, Niu M, Song S, Wei L, Chen G
J Mol Med (Berl). 2021; 99(7):1009-1020.
PMID: 33835216
DOI: 10.1007/s00109-021-02073-3.
Relationship Between Interleukin-6 -174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients.
Sokolik R, Iwaszko M, Swierkot J, Wysoczanska B, Korman L, Wiland P
Pharmgenomics Pers Med. 2021; 14:157-166.
PMID: 33536774
PMC: 7850562.
DOI: 10.2147/PGPM.S264555.
Genome-wide association study of circulating interleukin 6 levels identifies novel loci.
Ahluwalia T, Prins B, Abdollahi M, Armstrong N, Aslibekyan S, Bain L
Hum Mol Genet. 2021; 30(5):393-409.
PMID: 33517400
PMC: 8098112.
DOI: 10.1093/hmg/ddab023.
The Association between Neighborhood Disorder and Health: Exploring the Moderating Role of Genotype and Marriage.
Lei M, Simons R
Int J Environ Res Public Health. 2021; 18(3).
PMID: 33494231
PMC: 7908190.
DOI: 10.3390/ijerph18030898.
Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro.
Flynn C, Garbers Y, Dusterhoft S, Wichert R, Lokau J, Lehmann C
Sci Rep. 2020; 10(1):21612.
PMID: 33303781
PMC: 7730449.
DOI: 10.1038/s41598-020-77884-4.
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
Canziani L, Trovati S, Brunetta E, Testa A, De Santis M, Bombardieri E
J Autoimmun. 2020; 114:102511.
PMID: 32713677
PMC: 7342030.
DOI: 10.1016/j.jaut.2020.102511.
Interleukin Gene Variability and Periodontal Bacteria in Patients with Generalized Aggressive Form of Periodontitis.
Borilova Linhartova P, Danek Z, Deissova T, Hromcik F, Lipovy B, Szaraz D
Int J Mol Sci. 2020; 21(13).
PMID: 32630798
PMC: 7370291.
DOI: 10.3390/ijms21134728.
Treatment options in type-2 low asthma.
Hinks T, Levine S, Brusselle G
Eur Respir J. 2020; 57(1).
PMID: 32586877
PMC: 7116624.
DOI: 10.1183/13993003.00528-2020.
Soluble interleukin-6 receptor in patients with V617F somatic mutation and myeloproliferative neoplasm.
Garbers C, Rose-John S
EClinicalMedicine. 2020; 22:100340.
PMID: 32395711
PMC: 7205741.
DOI: 10.1016/j.eclinm.2020.100340.